To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbLaurus Labs Limited Share Price
breadcrumbValuation

Laurus Labs Limited Fundamentals

info2
Compare peers arrow

Market Cap

44,450.60 Cr.

Face value

2.00

Book value

82.40

Div. yield

0.15%

P/E ratio

124.05

P/B ratio

10.00

Debt/Eq.

0.60

Market Cap

44,450.60 Cr.

Face value

2.00

Book value

82.40

Div. yield

0.15%

P/E ratio

124.05

P/B ratio

10.00

Debt/Eq.

0.60
About Laurus Labs Limited
arrow

Laurus Labs Limited offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. The  Read more ▾

IndustryPharmaceuticals & Drugs
SectorHealthcare
Top subsidiaries
Sriam Labs Pvt Ltd.Laurus Bio Pvt Ltd. (Formerly Known as Richcore Lifesciences Pvt Ltd.)Laurus Synthesis Pvt Ltd.Laurus Specialty Chemicals Pvt Ltd.Laurus Holdings Ltd.Laurus Generics SA (Pty) Ltd.
MANAGEMENT
right
Executive DirectorKrishna Chaitanya Chava
Whole Time Director & Chief Executive OfficerSatyanarayana Chava
Non Executive Independent DirectorAruna Bhinge
Non Executive Independent DirectorRajesh Koshy Chandy
ChairmanRavindranath Kancherla
left
Executive DirectorKrishna Chaitanya Chava
Whole Time Director & Chief Executive OfficerSatyanarayana Chava
Non Executive Independent DirectorAruna Bhinge
Non Executive Independent DirectorRajesh Koshy Chandy
ChairmanRavindranath Kancherla
Executive Director & Chief Financial OfficerVenkata Ravi Kumar Vantaram
Executive DirectorLakshmana Rao CV
Company SecretaryG Venkateswar Reddy
Independent DirectorKarnam Sekar
Executive DirectorSoumya Chava
Executive Director & Chief Executive OfficerSatyanarayana Chava
Executive DirectorLakshmana Rao CV
Non Executive DirectorChandrakanth Chereddi
Non Executive Independent DirectorAruna Bhinge
ChairmanM Venu Gopala Rao
Non Executive Independent DirectorRajesh Koshy Chandy
Non Executive Independent DirectorRavindranath Kancherla
Executive Director & Chief Financial OfficerVenkata Ravi Kumar Vantaram
Company SecretaryG Venkateswar Reddy
Executive Director - SynthesisKrishna Chaitanya Chava
Non Executive Independent DirectorRamesh Subrahmanian
Whole Time Director & Chief Financial OfficerV Ravi Kumar
Non Executive Independent DirectorRajesh Koshy Chandy
Executive Director - GenericsSoumya Chava
Non Executive Independent DirectorAruna Bhinge
Whole Time Director & Chief Executive OfficerSatyanarayana Chava
ChairmanRavindranath Kancherla
Company Secretary & Compliance OfficerG Venkateswar Reddy
Non Executive Independent DirectorKarnam Sekar
Executive Director - QualityCV Lakshmana Rao
Executive DirectorKrishna Chaitanya Chava
Company Secretary & Compliance OfficerG Venkateswar Reddy
ChairmanRavindranath Kancherla
Whole Time Director & Chief Executive OfficerSatyanarayana Chava
Whole Time Director & Chief Financial OfficerV Ravi Kumar
Executive DirectorSoumya Chava
Non Executive Independent DirectorAruna Bhinge
Non Executive Independent DirectorRajesh Koshy Chandy
Non Executive Independent DirectorKarnam Sekar
Whole Time DirectorLakshmana Rao CV
Additional DirectorRamesh Subrahmanian
Other detail of Laurus Labs Limited
arrow
location
AddressLaurus Enclave, Plot Office 01 Edulapaka Bonangi Village, Parawada Mandal, Anakapalli ,Vishakhapatnam ,Andhra Pradesh-531021.
phone
Telephone0891 6821101 / 1102
email
globe
MORE DETAILS
NSE Code19234
NSE SymbolLAURUSLABS
SeriesEQ
ISININE947Q01028
Laurus Labs Limited offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. The company develops innovative medicines that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. It works with all the top generic pharmaceutical companies in the world. The company sells its APIs in many countries. Its major focus areas include anti-retroviral, Hepatitis C and Oncology drugs. Continuous innovation is the lifeblood of its business. Therefore, it undertakes dedicated RD in areas that have significant growth potential. The company has commercialised various products since inception across three distinct business units: Generics API, Generics FDF and Synthesis.
personal

Grow your wealth with more research recommendations

+91